CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 185 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 7.73 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $198,319,737 | 34.81% |
| Saturn V Capital Management LP | 524,811 | $20,163,239 | 11.18% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $166,956,377 | 9.97% |
| Altium Capital Management LP | 305,000 | $11,718,100 | 8.87% |
| MPM BioImpact LLC | 1,003,406 | $38,550,859 | 7.76% |
| Affinity Asset Advisors, LLC | 321,017 | $12,333,473 | 4.31% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,131,000 | $81,873,020 | 3.69% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,748,141 | $67,163,577 | 3.59% |
| Nan Fung Group Holdings Ltd | 113,950 | $4,377,959 | 2.80% |
| Vivo Capital, LLC | 934,879 | $35,918,051 | 2.48% |
| Nicholas Investment Partners, LP | 928,637 | $35,678,234 | 2.44% |
| Versor Investments LP | 348,543 | $13,391,022 | 2.32% |
| HARVEST MANAGEMENT LLC | 60,000 | $2,305,200 | 1.99% |
| TIG Advisors, LLC | 893,435 | $34,325,773 | 1.92% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 282,592 | $10,857,185 | 1.58% |
| Olympiad Research LP | 38,931 | $1,495,729 | 1.47% |
| Sand Grove Capital Management LLP | 315,973 | $12,140 | 1.42% |
| HighVista Strategies LLC | 76,021 | $2,920,727 | 1.34% |
| Eventide Asset Management | 1,927,000 | $74,035,340 | 1.25% |
| Magnetar Financial LLC | 1,262,060 | $48,488,345 | 1.06% |
External links
This page lists CHINOOK THERAPEUTICS INC's shareholders in Q2 2023. To view CHINOOK THERAPEUTICS INC's shareholder history, click here.